embolization, making it the predominant treatment option. 6 Endovascular treatment of intracranial aneurysms is accompanied by risks related to a variety of complications, some of which may occur in a delayed fashion in the hours following completion of the procedure. These periprocedural complications include ischemic or hemorrhagic stroke, cardiac events, and access site complications (ischemic or hemorrhagic). 2, 3, [8] [9] [10] 13 There are few published data regarding the timing, nature, and frequency of these complications, however. Most prior studies have not made the distinction between intraprocedural complications and complications that were only detected after the procedure. 9 In the present investigation, we sought to analyze the timing, rate, and nature of postoperative events in patients in whom the procedure was completed without apparent intraprocedural complications. These data may have important implications for defining acceptable postoperative monitoring for patients undergoing these procedures.
Methods
Patients who underwent elective endovascular treatment of unruptured cerebral aneurysms between March 2002 and June 2012 were identified from a prospective case log maintained for quality assurance purposes. Institutional review board approval was obtained for this retrospective review. Authors Arias and Patel reviewed procedure logs and hospital records for each admission.
Admissions for first-time treatment and treatment of recurrent aneurysms were included. The presentation, baseline patient characteristics, aneurysm size and location, and form of treatment of each cerebral aneurysm were recorded. All patients in whom treatment was initiated, including those with attempted but aborted procedures, were included. Patients with adverse intraprocedural events noted during the procedure, such as arterial perforation or thromboembolism, were excluded from this analysis.
All procedures were performed by 1 of 3 neurointerventional staff members and 1 of 2 neurointerventional fellows per year. Treatment with aspirin (325 mg per day) and clopidogrel (Plavix, Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership; 75 mg per day) was initiated at least 5 days prior to the procedure in anticipation of any possible intervention requiring temporary balloon occlusion or stent placement. All procedures were performed under general anesthesia, and in the majority of cases a 6.5-Fr sheath was placed in the right common femoral artery and routine diagnostic cerebral angiography was performed using a high-resolution biplane angiographic unit (Neurostar or Axiom Artis, Siemens). Systemic heparinization was initiated to maintain the activated clotting time at 250-350 seconds once the parent vessel harboring the aneurysm was catheterized. After the procedure, heparin was reversed. The femoral sheath was removed immediately following the procedure with closure of the arteriotomy with a mechanical closure device or manual compression at the discretion of the treating physician. All patients were monitored after the procedure in a neurological intensive care unit or a 24-hour postanesthesia care unit overnight, with discharge planned for the following morning.
All patients with unanticipated adverse events discovered or occurring after procedure completion and before hospital discharge were identified from chart review. Events were adjudicated based on review of these records as well as the results of imaging studies or laboratory results. Postprocedural events were categorized as intracranial hemorrhage (subcategorized as subarachnoid hemorrhage, intraparenchymal hemorrhage, and intraventricular hemorrhage), stroke, groin hematoma (if resulting in additional treatment or prolonged hospital stay), retroperitoneal hematoma, and cardiac events. The time from the completion of the procedure to event discovery was calculated. Procedure completion time was defined as the time recorded for the last angiographic image. Event discovery was determined based on chart review. Time of onset was recorded as the time that symptoms were recorded, or the time a diagnostic test that confirmed a postprocedural complication was ordered, which ever was earlier. For example, in a patient with a retroperitoneal hematoma, discovery time was recorded as the time when the first hematocrit was ordered if charting did not record symptom onset time. For each patient with a postoperative event, details regarding the treatment and outcome of the complication were collected for presentation in a vignette form.
Results
A total of 501 patients with unruptured cerebral aneurysms underwent 687 elective endovascular procedures between March 2002 and June 2012. Nine patients were excluded from our analysis due to intraprocedural events, for a total of 678 treatments in 492 patients who underwent routine postprocedural observation after an apparently uncomplicated procedure.
Most of the 492 patients were female (n = 402). Of the 678 procedures, 530 were first-time procedures, while 148 were performed on patients with aneurysms that recurred after previous open surgical or endovascular treatment. The patients' mean age (± SD) at the time of treatment was 56.5 ± 12.7 years. Endovascular procedures included coiling alone, stent-assisted coiling, balloon assisted coiling, Onyx HD 500 occlusion (eV3 Covidien Neurovascular), and Pipeline Embolization Device (eV3 Covidien Neurovascular). The aneurysm locations and types of treatment are shown in Table 1 .
Twenty-seven (4.0%) of the 678 procedures resulted in postprocedural complications: 3 intracranial hemorrhages (1 intraventricular, 1 subarachnoid and intraventricular, and 1 intraparenchymal), 6 ischemic strokes, 4 cardiac events, 5 retroperitoneal hematomas, and 9 groin hematomas requiring treatment or prolonged observation. The majority (20/27 or 74.0%) of these complications were detected within 4 hours from the procedure. Four of the 27 complications (14.8%) were detected between 4 and 12 hours, 1/27 (3.7%) between 12 and 24 hours, and 2/27 (7.4%) more than 24 hours after the procedure ( Table 2) .
The complications detected within 4 hours included 1 intracranial hemorrhage, 4 ischemic strokes, 4 cardiac events, 2 retroperitoneal hematomas, and 9 groin hema-tomas. All cardiac events and groin hematomas were detected within 4 hours. Complications occurring or detected greater than 4 hours from the conclusion of the procedure consisted of 2 intracranial hemorrhages detected on head CT obtained for evaluation of headaches and resulting in no permanent deficits, 2 ischemic strokes with minor deficits requiring inpatient rehabilitation after discharge, and 3 clinically asymptomatic retroperitoneal hematomas found due to falling hematocrit levels leading to abdominal CT scans that required no further intervention or treatment. All 3 patients with clinically asymptomatic retroperitoneal hemorrhage were observed and remained stable without intervention. All complications are detailed in the following case descriptions and in Table 3 .
Complications Detected Less Than 4 Hours Postprocedure
The intracranial hemorrhage occurred in an 86-yearold man who presented with coil compaction of a previously treated ruptured basilar tip aneurysm. He was receiving aspirin and clopidogrel prior to retreatment, and on the day of the procedure he was given an extra dose of 225 mg of clopidogrel and 325 mg of aspirin due to suboptimal platelet inhibition on testing performed the day prior. He underwent stent-assisted coil embolization without any intraprocedural events. Immediately after the procedure he was confused, and a head CT demonstrated a small amount of bilateral intraventricular hemorrhage. He was discharged to a rehabilitation facility with minimal physical impairment on postoperative day (POD) 3.
There were 4 patients with delayed ischemic stroke: a 45-year-old woman underwent successful coiling of a left middle cerebral artery (MCA) aneurysm. About 2 hours after the procedure she developed right upper-extremity weakness. Repeat angiography showed no abnormality but MRI demonstrated an acute cerebral infarction in a left MCA lenticulostriate territory. She was discharged to a rehabilitation facility with mild right upper-and lowerextremity weakness on POD 5.
A 62-year-old woman underwent uncomplicated left posterior communicating artery aneurysm coiling, but in the anesthesia recovery area, the patient was noted to have a left gaze preference and an 8-mm fixed and dilated right pupil. An emergent head CT demonstrated no abnormality. Subsequent MRI scans demonstrated infarction of the left posterior cerebral artery territory, including a small region of the posterior left thalamus. She required placement of a gastric feeding tube and was eventually discharged to a skilled nursing facility on POD 13. She was not following commands and had a left gaze preference and right-sided hemiparesis at discharge.
A 75-year-old woman underwent stent-assisted coil embolization of 2 left internal carotid artery (ICA) aneurysms. Immediately after the procedure she was slow to awaken, and then in the postanesthesia care unit was * ACoA = anterior communicating artery; ICA = internal carotid artery; MCA = middle cerebral artery; OphA = ophthalmic artery; PCoA = posterior communicating artery; PICA = posterior inferior cerebellar artery; SHA = superior hypophyseal artery. ICA (other) refers to branches or segments of the ICA other than the listed locations. aphasic with right hemiparesis. Repeat angiography showed no stent-associated thrombus or any other acute abnormality, but MRI showed a low apparent diffusion coefficient in the posterior limb left internal capsule and left peritrigonal white matter, consistent with hyperacute stroke in the left anterior choroidal artery distribution. She was discharged to a rehabilitation facility on POD 6 with residual right lower-extremity weakness.
A 65-year-old woman underwent uncomplicated stent-assisted coil embolization of a right paraclinoid aneurysm. Immediately postoperatively she developed a left hemiparesis. Repeat angiography showed no acute abnormality, and MRI showed acute watershed infarcts in the right cerebral hemisphere. Small embolic infarcts were seen in the head of the right caudate nucleus, left frontal lobe, and both cerebellar hemispheres. She was discharged to a rehabilitation facility with no motor function in her left arm and weakness in her left leg on POD 4.
There were 4 cardiac events detected within 4 hours from procedure conclusion. The first involved a 72-yearold woman who underwent coiling of an ICA aneurysm and developed non-ST-segment elevation with peak troponin values of 16. Cardiac catheterization revealed severe 3-vessel disease. The patient was offered a coronary artery bypass graft, but she declined and indicated that she wished to have this procedure done at an institution closer to her home.
The second case involved a 73-year-old woman who underwent balloon-assisted coil embolization of a right posterior communicating artery aneurysm. Following this procedure, the patient became hypotensive and myocardial infarction was diagnosed. Cardiac catheterization revealed a severe stenosis of the left main coronary artery and high-grade lesion of the right coronary artery. A coronary artery bypass graft procedure was delayed due to the administration of clopidogrel during the procedure and was performed 3 days later.
The third case was a 56-year-old woman who underwent uneventful coiling of a left ICA aneurysm at the origin of the ophthalmic artery. Postoperatively, while in the postanesthesia recovery unit, she was noted to be in atrial fibrillation with her heart rate in the 110s to 120s. She was treated with metoprolol and her heart rhythm converted to normal sinus rhythm.
The fourth case was a 61-year-old woman who underwent coiling of an anterior communicating artery aneurysm. Postprocedure she developed transient asymptomatic first-degree heart block lasting seconds on 2 occasions. The heart block was determined to be due to vagal stimulation. The patient was monitored on telemetry. No further intervention was pursued.
There were 2 cases of retroperitoneal hematomas detected within the first 4 hours. The first case was a 51-year-old woman who underwent coiling of an anterior communicating aneurysm. She developed lower right quadrant abdominal pain subsequent to the procedure. A large pelvic hematoma was identified on pelvic CT. It was managed with observation.
The second case occurred in a 56-year-old woman who underwent coiling of a left ICA aneurysm. During the first few hours of her hospitalization, she described a popping sensation in her right groin. A hematoma subsequently developed and was evaluated by the vascular surgery service. The patient underwent an ultrasound and was discovered to have a retroperitoneal hematoma as well as a right femoral pseudoaneurysm. She was taken to the operating room by the vascular surgery team for primary repair of her pseudoaneurysm, which was performed without complication.
There were a total of 9 groin hematomas that required observation and extended length of stay by at least 1 day. All were detected within the first 4 hours, but none required any further intervention.
Complications Occurring Between 4 and 12 Hours Postprocedure
One ischemic stroke occurred in a 65-year-old man who underwent successful coiling of a left anterior choroidal artery aneurysm. Eight hours after the procedure, he developed slurred speech and right hemiparesis. Head CT and repeat cerebral angiography showed no acute abnormality, but an MRI demonstrated an early subacute infarction within the left anterior choroidal artery distribution. He was discharged to a rehabilitation facility with mild dysarthria and right facial and extremity weakness on POD 5.
The other ischemic stroke occurred in a 66-year-old woman with a history of seizures who underwent stentcoil embolization of a broad-based, saccular aneurysm arising from the distal right vertebral artery just distal to the posterior inferior cerebellar artery. That evening, she developed mild dysarthria and a subtle left upper-extremity pronator drift. MRI demonstrated a small focus of diffusion restriction in the right thalamus. She was discharged to a rehabilitation facility on POD 3.
Two patients were found to have retroperitoneal hematomas, and both were detected by abdominal CT due to falling hematocrit levels. Otherwise both were asymptomatic. They were observed and both discharged to home without consequence.
Complications Occurring Between 12 and 24 Hours Postprocedure
The 1 complication detected between 12 and 24 hours after the procedure was an intracranial hemorrhage. It occurred in a 53-year-old woman with an anterior communicating artery aneurysm with adequate platelet inhibition on aspirin and clopidogrel prior to treatment. She underwent successful coil embolization of the aneurysm, but on the morning of POD 1 she complained of persistent headache with nausea and emesis. A head CT demonstrated small amounts of hemorrhage in the subarachnoid spaces over the cerebral convexities and a small amount of hemorrhage layering in the occipital horns of the lateral ventricles with mild dilation of both temporal horns. She was observed and then discharged without any complications on POD 5.
Complications Detected More Than 24 Hours From Procedure Conclusion
One intracerebral hemorrhage was detected more than 24 hours after the procedure conclusion. A 69-yearold woman with a left superior cerebellar artery aneurysm was pretreated with aspirin and clopidogrel; however, the VerifyNow (Accumetrics) clopidogrel test prior to her procedure showed less than 2% inhibition, and she was therefore given a bolus oral dose of 60 mg of prasugrel. She underwent successful and uneventful coiling of the aneurysm. On POD 2 she developed severe occipital headache and nausea and vomiting, and a head CT demonstrated a 1.8 × 1.2-cm right cerebellar hemorrhage. Her symptoms resolved and she made a full recovery and was discharged to home on POD 9.
One retroperitoneal hematoma was found on POD 1 after workup due to falling hemoglobin level and mild abdominal pain. The patient was observed and discharged home without complication.
Discussion
The present study provides good evidence from a large single-center case series that severe complications requiring urgent management are rare after the first 4 hours following uncomplicated elective endovascular aneurysm treatment. Transfer to a less intensive care setting for further observation would be reasonable to consider in some cases, particularly after 12 hours postprocedure.
Timing of Postprocedural Complications
Few studies have focused on the timing of postprocedural complications and most have reported procedural and early postprocedural events in aggregate.
2,3,8-10
Niskanen reported 6 procedural complications and no postoperative events in 53 patients with unruptured aneurysms undergoing endovascular treatment. 9 
Frequency of Complications
Prior publications have reported the procedural complications rates related to endovascular treatment of cerebral aneurysms. 10, 13 The most common complications are related to acute thromboembolic events and perforation of the aneurysm during treatment. Overall, the reported rate of thromboembolic complications ranges between 4.7% and 12.5%, while the rate of intraprocedural rupture of cerebral aneurysms is about 0.7% in patients with unruptured aneurysms and about 4.1% in patients with previously ruptured aneurysms. 10 A few studies, such as the ATENA (Treatment by Endovascular Approach of Nonruptured Aneurysms) study, 13 have focused on treatment of unruptured aneurysms only. The ATENA study demonstrated an overall rate of thromboembolic complications of 7.1% and an intraoperative rupture rate of 2.6% in 700 procedures. Adverse events associated with transient or permanent neurological deficit or death were encountered in 5.4% of cases. The 1-month morbidity and mortality rates were 1.7% and 1.4%, respectively. 13 The timing of these events was not reported.
In our series of 678 treatments (excluding treatments with intraprocedural complications such as aneurysm rupture, wire perforations, and witnessed thromboembolic events) our total postprocedural complication rate was 4.0% (27 postprocedural complications in 678 cases). A postprocedural intracerebral hemorrhage was detected after 3 (0.4%) of 678 treatments, ischemic stroke after 6 (0.9%), cardiac event after 4 (0.6%), and retroperitoneal or groin hematomas that either required further treatment or resulted in increased length of stay were detected after 5 (0.7%) and 9 (1.3%), respectively.
There were a total of 3 intracerebral hemorrhages detected after the procedure, without any evidence of intraprocedural perforation or rupture. These occurred in 3 (0.4%) of 678 cases and represented 3 (11.1%) of our 27 postprocedural complications. The origin and nature of these hemorrhages are unclear.
One possible contributing factor for development of intracerebral hemorrhages is the use of antiplatelet therapy. Literature from the field of interventional cardiology suggests that adding aspirin and clopidogrel dual antiplatelet therapy (DAPT) to postprocedural management minimizes the risk of thromboembolic complications 5 and is more benefcial than single-agent therapy with aspirin alone. 7, 17, 18 As a result, DAPT with full-dose aspirin (325 mg orally daily) and clopidogrel (75 mg orally daily) has also been recommended for neurointerventional surgery. 1, 15 Prior studies in coil embolization procedures have demonstrated that symptomatic thromboembolic complications (transient ischemic attack or stroke within 60 days) occurred in 4 (16%) of 25 cases when no antiplatelet drugs were given, in 2 (2.3%) of 86 cases when antiplatelet drugs were administered only after embolization, and in 5 (1.9%) of 258 cases when antiplatelet drugs were administered before and after embolization. 19 Our current practices reflect these observations. We tend to pretreat all of our patients with oral aspirin, 81 or 325 mg daily, unless contraindicated by an aspirin allergy. Since 1999, when clopidogrel became available, many patients also received clopidogrel for at least 3-5 days before their procedures. In a minority of cases, clopidogrel was given in loading doses of 300-450 mg immediately before procedures. Over the last decade we have begun to monitor preprocedural platelet inhibition levels, given reports in the cardiovascular literature that up to 50% of patients respond inadequately to clopidogrel and 5%-60% are resistant to aspirin.
14 In a minority of cases, the patients were given loading doses of aspirin and/or clopidogrel immediately before procedures due to inadequate platelet inhibition on preprocedure testing. Patients treated after procedures were generally given aspirin permanently and clopidogrel for 30-60 days. 19 In this series, 2 of the 3 patients with postprocedural hemorrhages were given boluses of aspirin and clopidogrel prior to the procedure due to inadequate platelet inhibition on preprocedure testing.
Symptomatic ischemic strokes occurred after 6 (0.9%) of our 678 procedures and represented 6 (22.2%) of our 27 postprocedural complications. Of these 6 ischemic strokes, 5 resulted in deficits requiring intensive inpatient rehabilitation at discharge, and in 1 case discharge to a skilled nursing facility was required.
Four of the 6 patients with ischemic strokes returned to the angiography suite for repeat angiograms to search for possible causes of their symptoms. All of these an- giograms were normal, without evidence of thrombus or vessel occlusion. All 6 patients with strokes had evidence of diffusion restriction or infarction on MRI, in territories that were consistent with their symptoms. The nature of these ischemic events is not entirely clear, as none of the patients had evidence of vessel-or coil/ stent-associated thrombus on follow-up imaging. Thromboembolic events are a known complication of endovascular aneurysm treatment. The rates of thromboembolic complications in unruptured aneurysm treatment range between 3.7% and 6.9%. 4, 11 The source of these emboli may be the catheters and guidewires used during the procedure, the surface of the coils or stents left in the aneurysms and vessels, iatrogenic vessel dissection, or stagnation of blood within flow-diverters or vessels in vasospasm.
10 Systemic heparinization is commonly used during procedures to reduce the occurrence of these events. Our patients generally receive systemic anticoagulation therapy with intravenous heparin during endovascular procedures (initial boluses of 70-100 U/kg followed by continuous infusions of 7-10 U/ kg per hour). Activated clotting times on heparin are monitored and maintained at twice the baseline value at least, usually at or near 300 seconds, by administration of additional boluses or by adjusting infusion rates, as needed. Heparin is generally discontinued at the conclusion of the procedure. 19 Previous studies have not revealed significant differences in the complication rate between balloon-assisted coiling and simple coil embolization. 12 In our series, 4 of 6 ischemic strokes occurred in patients treated with simple coil embolization, and 2 of 6 ischemic strokes occurred in patients treated with stent-assisted coiling. There was no permanent coil protrusion from the aneurysm at the conclusion of the procedure in any of these cases. No postprocedural strokes occurred in patients undergoing balloon-assisted coiling or treatments using the Pipeline Embolization Device.
Retroperitoneal or groin hematomas that either required further treatment or resulted in increased length of stay were detected after 5 (0.7%) and 9 (1.3%) of 678 treatments, respectively. There is little consensus in the literature on the rates of these types of complications, as they are rarely reported and are frequently not detected unless patients are overtly symptomatic or the hemorrhage is significant enough to cause a detectable drop in hematocrit or require further treatment.
Nature of Complications
Our series indicates that most complications are detected within the first 4 hours following the procedure. Fewer complications were detected between 4 and 12 hours, and even fewer after 12 hours. The severity of the complications also correlates with time of detection. Half of the complications detected within the first hours required further treatment or resulted in deficits at discharge. In contrast, all of the patients with complications detected more than 12 hours after the procedure were discharged home without deficits.
Of the 20 events that were detected within 4 hours from the conclusion of the procedure, 10 were retroperitoneal or groin hematomas that were observed and required no further treatment. Another 2 events were transient cardiac issues (atrial fibrillation in 1 patient, and firstdegree heart block in another) that required no further treatment. The remaining 8 events were 1 intraventricular hemorrhage in a patient who was eventually discharged to a rehabilitation facility, 4 ischemic strokes (3 of the patients were discharged to a rehabilitation facility and 1 to a skilled nursing facility), 2 cardiac events in patients who eventually required coronary artery bypass grafts, and 1 retroperitoneal hematoma with an associated femoral pseudoaneurysm that required surgical intervention.
The complications detected beyond 4 hours from the conclusion of the procedure were both rare (7 out of 678 procedures) and relatively minor. Between 4 and 12 hours, 2 patients had ischemic strokes; both patients were eventually discharged to a rehabilitation facility. Two other patients were found to have retroperitoneal hematomas, which were detected due to falling hematocrit levels, and both were observed and discharged home without consequence.
Only 3 complications were found beyond 12 hours after the procedure: 2 patients had intracerebral hemorrhages and were discharged without complication; 1 had a retroperitoneal hematoma and was observed and also discharged without complication. In our series, none of the complications that occurred after 4 hours after the procedure required intervention.
We acknowledge some limitations of this study. Our study design was a retrospective review that sought to detect all postprocedural complications; however, patients were identified from our quality assurance case log, which is prospective and unlikely to omit patients with adverse events. Detection of complications in this manner is highly dependent on an accurate, detailed, and complete medical record. Some complications may have been missed due to incomplete documentation. Furthermore, we depended on the presence of diagnostic tests to detect postprocedural complications. It is possible that some patients developed hemorrhagic or ischemic strokes that were not detected because they did not undergo postprocedural radiological imaging. Some retroperitoneal hematomas could have also been missed in a similar fashion. Cardiac events were dependent both on postprocedural symptoms and further investigations, such blood tests or electrocardiogram. We also limited our inclusion of groin hematomas only to those that caused a prolongation in hospital stay.
Our prospective database does not include followup data, and obtaining such data for all of our patients would be difficult. Furthermore, outcomes and long-term follow-up are beyond the scope of this paper, which focuses primarily on complications detected in the immediate postprocedural period.
Conclusions
These data provide useful and important information regarding the timing and nature of complications following uncomplicated endovascular treatment of patients with unruptured intracranial aneurysms. These findings have implications for postoperative monitoring. First, the large majority of complications occurred within the first 4 hours after awakening from general anesthesia. These patients require close observation and postanesthesia recovery unit staff should be aware of the nature of these complications, which include neurological, cardiac, and groin access problems. Second, beyond 4 hours, and certainly after 12, the risk of developing a clinically significant problem becomes much lower. It would be reasonable to consider transferring these stable patients to the floor if intensive-care beds were needed for other, more critically ill patients. These data are not sufficient to conclude that all patients should routinely be transferred to a floor environment 4 to 12 hours after an uncomplicated procedure. Further studies with greater numbers, as well as cost-benefit analyses, would be required to explore this more completely.
